AI-assisted drug discovery is not one software category. Retrieving a protein annotation, generating a candidate structure, running docking and writing an ML training pipeline are different jobs. A useful stack assigns each job to a suitable tool and makes the handoffs inspectable.

This guide separates source-described capabilities from proposed evaluation steps. The resources below span public-data retrieval, known-site triage, cheminformatics interfaces, hosted scientific calculations, vendor-described molecular generation and a paper-described programming agent. They do not constitute a tested integrated pipeline.

Start with the research decision

Define the decision before choosing an agent: which target deserves investigation, which observed binding site merits modeling, which molecules satisfy design constraints, or which predictive model should be evaluated?

For target identification, the resources here chiefly support protein discovery and evidence gathering—not autonomous confirmation that a target causes disease or is therapeutically actionable. For molecular generation, AIDDISON Explorer describes candidate creation against project criteria. For molecular-property prediction, distinguish retrieved database properties, calculated descriptors and model predictions rather than combining them into one undifferentiated score.

A proposed project brief should specify organism, protein identity or discovery query, modality, available structures, measured data, design constraints and the next experimental decision. Keep an evidence ledger with identifiers, retrieval dates, settings, raw outputs and unresolved questions. The chemistry AI stack guide provides broader role framing; the MCP selection guide helps narrow integration choices.

For agent roles and evaluation, see AI Agents for Chemistry.

Match each resource to its actual role

Resource Type and source-described role Inputs and outputs Evaluation gate
UniProt MCP (cyanheads) Third-party protein-data integration Function queries, accessions or identifiers → annotations, mappings and sequences Resolve species and annotation provenance
RCSB MCP (cnyambura) Third-party structure retrieval interface PDB IDs and endpoint queries → metadata, polymer records and downloaded files Confirm relevant entity and accessible coordinates
PocketScout MCP Known binding-site triage server Target identifiers and site residues → contact evidence, ligand history, conservation and interpretations Inspect evidence behind site ranking
PubChem PUG REST Hosted HTTP API, not an MCP server Chemical identifiers or structures → selected records, properties and assay summaries Confirm compound identity and requested operation
RDKit MCP Server (TandemAI) Interface to RDKit software Client-selected exposed tools → tool results and assistant responses Inspect tool inventory and input/output schemas
AIDDISON Explorer Hosted molecular-design platform Target profile and design constraints → generated, scored and ranked candidates Review prediction uncertainty and feasibility
Rowan Hosted molecular-calculation platform Molecular or protein–ligand structures and settings → workflow-specific calculations Check method suitability and preparation
DrugAgent (Liu et al.) Paper-described multi-agent ML programming framework Task description, starter files and evaluator → implemented solutions and reports Audit code, evaluation design and actual execution

An MCP interface supplies access to tools; it is not itself a scientific prediction model. Likewise, a Skill is instructional material, not a replacement for runtime dependencies or scientific engines. Host support differs. See agents and Skills for those distinctions.

Establish protein identity before interpreting structures

UniProt MCP supports function-oriented search, sectioned annotations, identifier mapping, taxonomy, proteomes and canonical or optional isoform sequences. Search defaults to reviewed Swiss-Prot entries, and annotation outputs retain curation indicators and available PubMed/ECO evidence.

Use these features to assemble a target dossier, then make an explicit identity decision. A gene symbol alone is insufficient as a workflow handoff: retain the organism, resolved accession, selected sequence and relevant isoform or variant context. Missing annotation fields should remain missing rather than becoming negative biological conclusions.

Mapping and retrieval require state handling. A running mapping job returns a ticket for polling; completed results may have separate page continuations. An oversized annotation record can return an outline requiring section-specific follow-up. Proposed orchestration should preserve these states and record per-accession failures rather than silently dropping unresolved proteins.

Retrieve structures, then assess known sites

RCSB MCP retrieves entry metadata, polymer details and structure files, including mmCIF. Custom queries provide access to documented Data API endpoints. Its organism-search tool returns instructions and example queries—not a retrieved structure set. Structure discovery therefore needs an explicit route, such as protein cross-references or PocketScout’s related-structure tool.

PocketScout analyzes contacts around co-crystallized ligands using gemmi and consolidates observed pockets across structures by recurrence. It also gathers biological context, ligand bioactivity history, literature, conservation and known variants. Its tools return raw information alongside an interpretation field.

This is known-site intelligence, not new pocket prediction. Do not interpret an empty contact result as proof that a protein lacks bindable sites, or recurrence as experimental validation of a design hypothesis. Computational pocket prediction and ensemble-based allosteric detection are not documented current PocketScout capabilities.

For a proposed site-selection review, compare structural coverage, ligand-contact residues, biological relevance and supporting literature. Inspect raw evidence before accepting an interpretation. Conservation uses local-context matching against mouse, rat and cynomolgus macaque, not full multiple sequence alignment; uncertain residue correspondence warrants separate review.

Separate chemical retrieval from cheminformatics computation

PubChem PUG REST accepts identifiers including CID, name, SMILES, InChI and InChIKey. Its operations include selected record retrieval, property tables, assay summaries, and identity or similarity searches. Output formats depend on the operation. This is database access, not a newly trained property model or experimental validation of bioactivity.

RDKit MCP exposes RDKit functions through an MCP client and includes a tool-listing utility, an OpenAI-powered CLI client and an evaluation suite. However, full RDKit function coverage is a stated goal, not established coverage. The supplied excerpts do not enumerate molecular input formats or individual tool schemas.

A proposed chemical-quality gate should therefore start by inspecting available tools. Request identity checks or descriptors only when the discovered schemas support them, and compare outputs with a separately specified reference procedure. The repository’s LLMJudge can assess tool use and responses, but it does not substitute for scientific reference checks. The RDKit AI workflow guide offers related workflow framing.

Compare Rowan and AIDDISON Explorer by stage

AIDDISON Explorer’s vendor-described workflow begins with a target profile and molecular design constraints. Reinforcement-learning models based on REINVENT 4.0 generate candidates, which are scored across potency, physicochemical, developability and ADMET criteria. ADMET predictions include confidence and explainability information. Synthetic accessibility scoring and SYNTHIA API routes add feasibility considerations. Ranked candidates and predicted properties can be exported in CSV, SDF and RD formats.

Rowan supplies a hosted calculation environment with browser access and a Python API for job submission, monitoring and analysis. Its listed workflows include conformational searching, pKa and solubility prediction, descriptors, protein preparation, docking, batch and analogue docking, molecular dynamics and relative binding free-energy perturbation.

Choose Explorer when evaluating constraint-driven molecular generation and candidate prioritization. Choose Rowan when evaluating specified calculations on molecular or protein–ligand systems. Their property-related features overlap, but their documented workflow roles are not identical or interchangeable.

An Explorer-export-to-Rowan handoff is a proposal, not established interoperability. Before attempting it, check accepted structures, preparation requirements, retained identifiers and whether exported prediction metadata survives conversion. Explorer’s source does not establish an unrestricted public API or local installation route.

Use DrugAgent for a bounded modeling question

DrugAgent’s paper describes an LLM Planner that proposes and revises ML strategies and an LLM Instructor that implements them using domain-specific guidance. The Instructor can read and edit scripts, execute code, and return performance or failure reports. Guidance covers biological data acquisition, representations and domain-specific models.

The reported studies concern binary-classification workflows using PAMPA, HIV and DAVIS. They do not establish a general molecular generator, docking engine or production discovery system. The authors explicitly caution against direct deployment because of risks including hallucinated or fabricated results.

A proposed downstream use is to investigate a clearly defined predictive task after curating suitable measured labels. Supply starter data, a fixed evaluator, split rules and an iteration budget. Require inspectable code and execution artifacts. Connecting DrugAgent to the MCP resources or platform exports discussed here would require separate engineering and evaluation; it is not a documented completed integration.

Proposed example: evidence-to-candidate prioritization

Consider an explicitly proposed EGFR small-molecule campaign, using PDB 1M17 as an initial structural reference because PocketScout’s documentation uses it in an example. No results are asserted here.

  1. Define the objective. Input a human EGFR project brief, scaffold constraints and desired property criteria. Output a design specification. Decide which criteria are hard exclusions and which are ranking preferences.
  2. Resolve the target. Use UniProt MCP to obtain the accession, sequence and relevant annotations. Output an evidence-linked dossier. Pause if species, isoform or variant identity remains ambiguous.
  3. Inspect structural evidence. Retrieve entry and polymer metadata plus coordinates through RCSB MCP. Use PocketScout to assess observed ligand contacts, related structures, ligand history and variants. Output a reviewed site rationale, not a claim of a newly discovered pocket.
  4. Assemble and expand candidates. Use PubChem for focused reference-compound retrieval. If accessible, evaluate Explorer for scaffold-focused expansion under the design specification. Output candidate structures with source identifiers, prediction metadata and route information where available.
  5. Apply chemical and modeling gates. Inspect RDKit MCP tools before proposing supported checks. Evaluate Rowan preparation, docking and selected property calculations on a bounded candidate set. Verify every transfer preserves molecular identity; this handoff remains proposed.
  6. Review the shortlist. Output an auditable table separating retrieved facts, predictions, docking outputs and unresolved concerns. Decide what warrants laboratory follow-up. Add DrugAgent only if a separate labeled modeling question justifies it.

Handle failures and choose an operating model

For PubChem, encode special URL characters, use documented POST handling for InChI or SDF inputs, respect request limits and dynamic throttling, and use bounded retries. Large collections should not become unrestricted per-record request streams.

For MCP tools, preserve partial failures, pagination and asynchronous state. RCSB downloads return a local path: verify that the downstream process can actually access the file. Treat unavailable coordinates, missing labels and failed calculations as recorded gaps, not values to be invented by an assistant.

Local operation also has distinct requirements. PocketScout requires Python 3.11 or later and is marked Alpha. RCSB project metadata requires Python 3.13 or later. UniProt’s README prerequisite says Bun v1.3.0 or higher, while package metadata requires Bun >=1.4.0; check the selected package metadata before deployment. General MCP support does not prove compatibility with a particular host.

PocketScout and TandemAI RDKit have supplied MIT license texts; UniProt MCP has Apache-2.0. RCSB’s README declares MIT, but separate license text was not supplied. DrugAgent’s paper links code, yet the available repository excerpt establishes neither setup nor code licensing. Rowan, Explorer and PubChem service access do not establish locally available implementation code or repository licenses. Software, upstream data and hosted-service terms need separate consideration.

Reader checklist

  • Define the research decision and stopping conditions before orchestration.
  • Resolve organism, protein sequence, structure entity and compound identity.
  • Keep retrieved records, calculations and predictions in separate columns.
  • Inspect PocketScout evidence and RDKit MCP tool schemas.
  • Confirm file access and format requirements at every proposed handoff.
  • Record missing data, failed jobs, settings and prediction uncertainty.
  • Review structural assumptions, assay context and model applicability before ranking.
  • Require experimental follow-up for activity, safety and synthesis claims.

Continue with these related guides: Protein & Structural Biology AI Workflow.

Sources

Primary support comes from the DrugAgent paper, project documentation for PocketScout, UniProt MCP, RCSB MCP and RDKit MCP, the PubChem specification and operational tutorial, and official product descriptions for Rowan and AIDDISON Explorer. Platform descriptions are vendor claims, not independent validation.